Skye Bioscience Receives Nasdaq Listing Deficiency Notice
Skye Bioscience (SKYE) has received a deficiency notice from Nasdaq due to its common stock trading below the minimum $1.00 bid price requirement. The notice indicates a compliance issue that the…






